SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 357 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.86 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $39,535,000 | +139.1% | 228,782 | +59.0% | 0.09% | +129.3% |
| Q4 2014 | $16,538,000 | -76.3% | 143,887 | -67.8% | 0.04% | -75.4% |
| Q3 2014 | $69,740,000 | +97.7% | 446,359 | +56.1% | 0.17% | +87.6% |
| Q2 2014 | $35,270,000 | +7.7% | 285,936 | -9.5% | 0.09% | -4.3% |
| Q1 2014 | $32,734,000 | +22.7% | 315,930 | +6.5% | 0.09% | +14.8% |
| Q4 2013 | $26,674,000 | +277.3% | 296,571 | +180.5% | 0.08% | +224.0% |
| Q3 2013 | $7,070,000 | +697.1% | 105,711 | +688.0% | 0.02% | +525.0% |
| Q2 2013 | $887,000 | – | 13,415 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $34,482,000 | 18.91% |
| NORTH RUN CAPITAL, LP | 490,000 | $56,321,000 | 5.02% |
| Visium Asset Management, LP | 3,076,092 | $353,568,000 | 4.99% |
| BOW STREET LLC | 112,979 | $12,986,000 | 4.60% |
| 1492 Capital Management LLC | 62,397 | $7,172,000 | 4.49% |
| CLOVIS CAPITAL MANAGEMENT LP | 115,000 | $13,218,000 | 3.70% |
| Paulson & Co. | 5,806,000 | $667,342,000 | 3.45% |
| HealthCor Management, L.P. | 525,000 | $60,344,000 | 3.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 158,500 | $18,218,000 | 3.10% |
| AMI ASSET MANAGEMENT CORP | 299,276 | $34,399,000 | 3.01% |